Navigation Links
Encouraging Gene Therapy Results in Genetic Form of Blindness
Date:9/8/2008

eport efficacy and safety. LCA can now be redefined as a potentially curable eye disease," said Samuel G. Jacobson MD, PhD, Professor of Ophthalmology at the University of Pennsylvania and Principal Investigator of the study. "This is a major source of encouragement to the patients and to all the scientists and clinicians who have spent decades building the knowledge base to the level where we could begin these clinical trials."

Human Gene Therapy, the Official Journal of the European Society of Gene and Cell Therapy (http://www.esgct.org), the British Society for Gene Therapy (http://www.bsgt.org), and the French Society of Cell and Gene Therapy (http://www.sftcg.fr) is an authoritative peer-reviewed journal published monthly in print and online that presents reports on the transfer and expression of genes in mammals, including humans. Related topics include improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, as well as ethical, legal, and regulatory issues related to the gene transfer in humans. Tables of contents and a free sample issue may be viewed online at http://www.liebertpub.com/hum

Mary Ann Liebert, Inc (http://www.liebertpub.com), is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Tissue Engineering, Stem Cells and Development, and Cloning and Stem Cells. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A
'/>"/>

SOURCE Mary Ann Liebert, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
2. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
3. Actress and Mother Jennifer Garner Kicks Off American Lung Associations Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza
4. New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need
5. Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
6. PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium
7. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
8. Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
11. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals ... VRX) has priced its previously announced public offering of ... Company will issue 23,529,412 common shares at a price ... approximately $2.0 billion. The Company will file a final ... Form S-3 and will make a similar filing with ...
(Date:6/18/2013)... June 18, 2013 /PRNewswire-iReach/ -- Today E-T-A Circuit ... Appliance Inlet Module. The X3130, integrated with E-T-A,s ... a C14 appliance inlet module, rocker switch and ... three-in-one device allows design engineers to streamline the ... installation time by 66 percent - and reduce ...
(Date:6/18/2013)... Inc. (NYSE: ACT ) today announced that Actavis ... Exchange Commission (SEC) a registration statement on Form S-4 in ... plc (NASDAQ: WCRX ), which included a joint ... "Form S-4"). As previously announced on May 20, ... a definitive agreement pursuant to which Actavis will acquire ...
Breaking Medicine Technology:Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Three-in-One X3130 Appliance Inlet Module 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7
... BPUR ) announced today that the U.S. ... protocol for review by the Food and Drug,Administration ... Hemopure(R),[hemoglobin glutamer - 250 (bovine)], or HBOC-201, for ... without,availability of blood transfusions. The proposed trial hypotheses ...
... DPS(TM) Allows Patients To Breathe Without Ventilator ... Clinical Trials Also Underway For ALS Patients, ... announced today it has received approval from,the U.S. Food ... Spinal Cord Injury (SCI) patients who lack voluntary,control of ...
Cached Medicine Technology:U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R) 2U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R) 3Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 2Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 3Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 4Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 5Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 6
(Date:6/18/2013)... 2013 The Temp1000IS temperature data ... device which can be used to automatically record temperatures ... of the Temp1000IS comes with the serial number and ... IFC400 (sold separately) docking station and can be ... No more removal of end-caps to download data. The ...
(Date:6/18/2013)... Parker Waichman LLP , a ... victims injured by defective medical devices, reports that the ... bone graft products are now available. Published this week ... two studies serve up two key findings: There is ... and the traditional bone graft; and there is “substantial ...
(Date:6/18/2013)... Senior drug regulatory officials from mainland China and ... the first time in the U.S.—the need for more collaboration ... process in a timely manner. Representatives from the Taiwan and ... practices and processes in drug review during the Convergence ... DIA 2013 49th Annual Meeting . , ...
(Date:6/18/2013)... Tarrytown, NY (PRWEB) June 18, 2013 ... simply to grow in size. Quite the opposite. ... and audiology practice-with over 140 expertly trained physicians offering ... communities in 40 locations throughout the Greater New York ... the important circumstances are right. And that includes the ...
(Date:6/18/2013)... June 18, 2013 Palo Alto has taken ... America's greenest cities with its recent major long-term solar power ... three major solar electric power purchase agreements , which together ... (MWh) of solar photovoltaic electric power per year, which is ... needs. That’s enough power to supply all 65,000+ Palo ...
Breaking Medicine News(10 mins):Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3
... Saarland Clinic Blood Center Chooses Inlog,s EdgeBlood and ... April 7 Global Med Technologies, Inc. ("Global ... an international healthcare information technology company, today announced ... Inlog subsidiary has licensed its EdgeBlood(TM) blood information ...
... of anti-aging injections continue, as do false claims and risk ... ... Physicians Coalition for Injectable Safety , There is no debating ... themselves, particularly in appearance enhancing treatments that restore youth and erase ...
... noses are more sensitive to body odors , , TUESDAY, April ... and detect male body odor, but men don,t have the ... women may be more sensitive to biologically relevant information in ... , "It is quite difficult to block a woman,s awareness ...
... of Northeast Florida , in collaboration with national, state ... to complete their advance healthcare directives -- an effort ... April 16, 2009 as ... public awareness of the need for advance care planning, ...
... The U.S. Departments of Defense and Veterans ... the success of the agencies, joint internal data synchronization ... clean, synchronized data, the DoD and VA have been ... through product price reductions, including $11 million in 2008. ...
... Orthopedic Stem Cell Market to Reach $228 Million by ... by iData Research ( www.idataresearch.net ), an international medical ... for stem cells used in orthopedic therapy will grow ... currently focused on spinal fusion surgery, mostly for arthritis, ...
Cached Medicine News:Health News:Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center 2Health News:Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center 3Health News:Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center 4Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 2Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 3Health News:Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions 4Health News:What's That Smell? Ask a Woman, Not a Man 2Health News:Community Hospice Supports National Healthcare Decisions Day 2Health News:Community Hospice Supports National Healthcare Decisions Day 3Health News:DoD and VA Recognize Innovative Healthcare Manufacturers for Excellence in Supply Chain Data Quality 2Health News:DoD and VA Recognize Innovative Healthcare Manufacturers for Excellence in Supply Chain Data Quality 3Health News:DoD and VA Recognize Innovative Healthcare Manufacturers for Excellence in Supply Chain Data Quality 4Health News:U.S. Orthopedic Stem Cell Market to Grow 68% in 2009 2
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
Medicine Products: